Tango Therapeutics, Inc. (TNGX) revenue

Revenue · fiscal 2025
$62.38M

Tango Therapeutics, Inc. (TNGX) reported revenue of $62.38M in fiscal 2025 (the year ended December 31, 2025). That is 48.3% higher than the $42.07M of fiscal 2024. Figures as of 18 Nov 2026, 11:32 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$62.38M
Change on fiscal 2024
+48.3%
Growth, 5 years
+52.1% a year
Highest on record
$62.38Mfiscal 2025
Lowest on record
$7.66Mfiscal 2020
Fiscal years on record
62020–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Tango Therapeutics, Inc. revenue, in more detail

Over the five fiscal years to 2025 revenue grew at a compound 52.1% a year. Across the 6 fiscal years on record (2020–2025), the highest was $62.38M in fiscal 2025 and the lowest $7.66M in fiscal 2020.

History · 6 fiscal years

Revenue by fiscal year

Tango Therapeutics, Inc. revenue, year by year

Tango Therapeutics, Inc. (TNGX) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$62.38M 48.3% up
2024$42.07M 15.2% up
2023$36.53M 46.9% up
2022$24.86M 32.9% down
2021$37.04M 383.8% up
2020$7.66M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

More on TNGX

Tango Therapeutics, Inc., figure by figure

Tango Therapeutics, Inc. (TNGX) overview: price, valuation and scorecard

Tango Therapeutics, Inc. revenue: questions and answers

What is Tango Therapeutics, Inc.'s revenue?

Tango Therapeutics, Inc. (TNGX) reported revenue of $62.38M in fiscal 2025 (the year ended December 31, 2025). That is 48.3% higher than the $42.07M of fiscal 2024.

What is the growth rate of Tango Therapeutics, Inc.'s revenue?

Over the five fiscal years to 2025 revenue grew at a compound 52.1% a year.

What are the highest and lowest revenue figures on record for Tango Therapeutics, Inc.?

Across the 6 fiscal years on record (2020–2025), the highest was $62.38M in fiscal 2025 and the lowest $7.66M in fiscal 2020.

How is Tango Therapeutics, Inc.'s revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For Tango Therapeutics, Inc. it is on record here for 6 fiscal years, 2020 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Tango Therapeutics, Inc. (TNGX) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/TNGX/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.